CNS Drugs

When Should Triptans be Taken During a Migraine Attack?
pp. 583-587(5)
Author: Schoenen J.

Do Statins Afford Neuroprotection in Patients with Cerebral Ischaemia and Stroke?
pp. 589-596(8)
Authors: Vaughan C.J.; Delanty N.; Basson C.T.

CNS Involvement in Primary Sjögren's Syndrome: Prevalence, Clinical Aspects, Diagnostic Assessment and Therapeutic Approach
pp. 597-607(11)
Authors: Govoni M.; Padovan M.; Rizzo N.; Trotta F.

Harnessing the Clinical Potential of Antiepileptic Drug Therapy: Dosage Optimisation
pp. 609-621(13)
Authors: Perucca E.; Dulac O.; Shorvon S.; Tomson T.

Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Optimal Intensity of Anticoagulation
pp. 623-631(9)
Authors: Yasaka M.; Yamaguchi T.

Adverse Effects of Antiepileptic Drugs on Bone Structure: Epidemiology, Mechanisms and Therapeutic Implications
pp. 633-642(10)
Authors: Pack A.M.; Morrell M.J.

Venlafaxine Extended-Release: A Review of its Use in the Management of Major Depression
pp. 643-669(27)
Authors: Wellington K.; Perry C.M.